The State of Inpatient Mental Health and Substance Use Treatment in 2023

**Understanding Inpatient Mental Health and Substance Use Treatment in 2023** The mental health crisis in the United States has reached a pivotal point, particularly in how treatment is accessed and covered by insurance. Recent data reveals that about **20% of individuals with private health coverage experience some form of mental illness**, with a further **5% grappling with serious mental health issues**. This raises alarms about the adequacy of support systems in place for a significant portion of the population. Research focused on those aged 18 to 64 covered by large employer-sponsored plans indicates that individuals enrolled in private insurance account for roughly **26% of all inpatient admissions** for mental health and substance use disorders. In comparison, **Medicaid** covers **41%** of these admissions, while **Medicare** accounts for **22%**. This disparity highlights the critical role public programs play in mental health treatment, and it sparks questions about how private insurance aligns with the actual needs of patients. Utilizing claims data from the **2023 Merative MarketScan Commercial Claims Database**, this report not only identifies the most prevalent diagnoses for inpatient treatment but also delves into the associated financial burdens. The analysis defines inpatient treatment as hospital stays requiring overnight accommodation, whether for psychiatric care, substance use hospitalization, residential rehabilitation, or detoxification services. It's worth clarifying that this analysis excludes emergency department visits unless they resulted in a formal admission. ### Key Insights on Treatment Costs and Diagnoses In 2023, **10% of all commercial inpatient stays** were attributed to mental health and substance use, equating to about **32 admissions per 10,000 enrollees**. Among these, the predominant diagnosis for 54% of admissions was mental health issues, notably depression, while 46% were related to substance use disorders. Digging deeper, **the average total cost for a mental health inpatient stay stood at $15,900**, while those for substance use averaged slightly lower at **$15,500**. The bulk of these individuals—**82% for mental health and 65% for substance use**—only required a single inpatient treatment during the year. These costs reflect a broader financial strain, especially seeing that patients covered by private insurance are responsible for about **9% of the overall costs** associated with their admissions, which is markedly higher than the usual out-of-pocket responsibility for hospitalizations. ### Broader Context of Accessibility and Quality This escalating cost for treatment, paired with the **unmet care needs**—as evidenced by about **40% of insured adults** in poor mental health reporting not receiving necessary care—emphasizes that financial investments in mental health services do not necessarily equate to effective accessibility. **Policy changes** are also evolving, yet enforcement of the **Mental Health Parity and Addiction Equity Act (MHPAE)** remains a significant hurdle. Furthermore, while quality measures were not the focal point of this analysis, tools like the **Inpatient Psychiatric Facility Quality Reporting** can provide insights into treatment effectiveness and patient outcomes. The narrative emerging from this data is complex, conveying a system where the rising costs of care collide with challenges in accessibility and quality—suggesting that while spending may be ramping up, many system-level issues remain persistently unresolved. What does this mean for anyone involved in the mental health sector? The current trends are concerning. For treatment providers, understanding these dynamics can help advocate for better systems and practices. For insurers and policymakers, there’s an urgent need to ensure that increasing expenditures translate into accessible and quality care for all those in need.The recent analysis sheds light on the evolving landscape of inpatient mental health and substance use treatment, revealing some critical insights into not just the lengths of stay but also the mounting costs to patients. For many seeking rehabilitation or detoxification, the average stay clocks in at just six days for rehab and four days for detox. These averages raise an important question: Are such brief treatments enough for the complexities of substance use disorders? Diagnosis and comorbidities play significant roles in determining the required length of stay, with more complicated cases often necessitating extended care. However, the current treatment duration may not align with what many patients genuinely need for recovery. This disconnect is concerning, especially given the statistics showing that one in four inpatient mental health admissions incurs out-of-pocket costs exceeding $1,900.

The Financial Burden on Patients

Digging into the costs associated with inpatient care, the financial implications are severe. With patients typically responsible for around 9% of total treatment costs, the average out-of-pocket expenses hit $1,300 for mental health admissions and $1,400 for substance use treatment. What's alarming is how these figures can skyrocket depending on the insurance structure. For example, those enrolled in employer-sponsored plans with Center of Excellence programs may face lower or even waived costs, but this isn’t the norm for every patient. Interestingly, research indicates that those seeking outpatient mental health treatment can still face significant financial hurdles, even with insurance. A study found that individuals with depression have noticeably higher out-of-pocket expenses than those without mental health diagnoses, revealing an annual gap of over $600, which widens as the severity of depression increases. If you’re navigating this sector, these financial dynamics could inform how you advise patients or structure treatment plans.

Understanding the Data

The insights come from a comprehensive analysis utilizing data from the Merative Health Analytics MarketScan database, covering 13 million adults aged 18 to 65 with employer-sponsored health plans. The selected cases provide a crucial snapshot of treatment patterns, reflecting the struggles and costs faced by a significant portion of those in need of mental health care. However, it’s essential to consider how the data may overlook patients with complex cases involving physical comorbidities. If a patient enters treatment for a mental health issue yet requires surgery for a separate ailment, their treatment may be categorized under physical health, masking the reality of mental health needs. In conclusion, while the statistics presented here paint a picture of the state of inpatient treatment for mental health and substance use, they also shine a light on the ongoing gaps in care and rising costs. As the industry evolves, these insights serve as a call to action for both providers and policymakers to reassess what constitutes adequate and affordable treatment for those grappling with these significant health challenges.